News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceuticals Corporation Executive, President Of Enzo Biochem Therapeutics Unit
October 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Gary C. Cupit, PharmD, to the newly created position of President of Enzo Therapeutics, Inc.
Twitter
LinkedIn
Facebook
Email
Print
People
Novartis
MORE ON THIS TOPIC
Podcast
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
March 18, 2026
·
1 min read
·
Heather McKenzie
Venture capital
Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers
March 18, 2026
·
2 min read
·
Tristan Manalac
Funding
R1 Leads Busy Fundraising Day With $77.5M Series A Raise for Kidney Disease
March 18, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Bicycle Downsizes by 30% After Deprioritizing Lead Program
March 18, 2026
·
37 min read
·
BioSpace Editorial Staff
